易鑫(吉因加董事长)

易鑫,男,1984年10月生人,中科院北京基因组研究所基因组学遗传学博士。现任北京吉因加科技有限公司董事长兼首席技术官,长期从事基因组医学、转化医学领域的科学研究和技术研发,曾任华大医学首席运营官、华大基因研究院副院长。

部分论文
Xin Yi, Yu Liang,.. Jian Wang, et al. Sequencing of 50 human exomes reveals adaptation to high altitude. Science. 2010 Jul 2;329(5987):75-8. doi: 10.1126/ science.1190371.
Xiaoming Wei,..Liying Cui* and Xin Yi*. Targeted next-generation sequencing as a comprehensive test for patients with and female carriers of DMDBMD a multi-population diagnostic study. Eur J Hum Genet. 2014 Jan;22(1):110-8. doi: 10.1038/ejhg.2013.82.
Rui Gao,.. Xin Yi*, Jun Wang* and Torben Hansen*. Evaluation of a target region capture sequencing platform using monogenic diabetes as a study-model.BMC Genet.2014 Jan 29;15:13. doi: 10.1186/1471-2156-15-13.
Shuqi Xie,.. Ling Yang and Xin Yi*. Detection of truncated dystrophin lacking the C-terminal domain in a Chinese pedigree by next-generation sequencing.Gene. 2012 May 10;499(1):139-42. doi: 10.1016/j.gene.2012.03.029.
Gang Liu,.. Yi Yang and Xin Yi*. A novel mutation of the SCL25A13 gene in a Chinese patient with citrin 2 deficiency detected by target next-generation sequencing. Gene. 2014 Jan 10;533(2):547-53. doi: 10.1016/j.gene.2013.10.021.

参考阅读
http://www.biolink.org.cn/2017cancerasia/yx.html
http://www.geneplus.org.cn/trans/toAboutUs#coreTeam

相关文章

开始在上面输入您的搜索词,然后按回车进行搜索。按ESC取消。

返回顶部